ARCHIVES

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

CCOPs Payline Set At 211, Winners Lister; NCI Will Fund Only 51 Unless More Funds Added

March 16, 1990

In Brief: New Presidents Take Office At ONS, ONCC, ARS; Baird Wins Awards; New VP In Houston

July 8, 1994

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986